Method AI, led by CEO Doug Teany, is a Boston, MA-based medical technology company focused on improving oncology outcomes through image-guided surgical navigation. The company is developing a novel surgical ultrasound platform that visualizes anatomy deep below the visible surface of an organ and creates a 3D subsurface map for physicians. Its platform provides real-time guidance against an AI-generated surgical plan to assist procedures. Method AI aims to improve cancer-free survival rates for patients and has a stated potential to reduce over $1 billion in annual healthcare costs. The company raised $20M in Series A funding to support continued development of this surgical ultrasound platform.

Total raised

$20M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2025